DrSaud1

Bullish Momentum on NKE Aiming for $108-$121 Targets

Long
Nike (BATS:NKE)  
BATS:NKE   Nike
After a thorough analysis of Nike, Inc. (NKE) on the charts, I've observed that we're currently in an upward trend, indicating strong bullish momentum. This analysis is grounded on several technical indicators and chart patterns that suggest continued growth potential in the near term.

Key Highlights:

Current Trend: The stock has been exhibiting a robust upper trend, with price action consistently forming higher highs and higher lows. This trend is supported by strong trading volumes and positive market sentiment towards the company.

Target Levels: Based on the current momentum and technical indicators, I'm targeting the $108-$121 price range. This range is identified by analyzing historical resistance levels and the gap down areas that have now turned into potential targets as the stock moves upwards.

Technical Indicators: Several technical indicators support this bullish outlook. The Moving Average Convergence Divergence (MACD) shows a bullish crossover, while the Relative Strength Index (RSI) remains in a healthy range, avoiding overbought territory. Additionally, support levels have been rising, further reinforcing the stock's strength.

Gap Down Areas: The specific focus is on the $108-$121 gap down areas from previous trading sessions. These gaps represent potential resistance turned support levels, offering an excellent opportunity for gains as the stock aims to fill these gaps in its upward trajectory.

Conclusion:

The combination of a strong upper trend, supportive technical indicators, and the aim to fill the gap down areas provides a compelling case for bullish positions in NKE. While the market remains unpredictable, the current technical analysis suggests that NKE is on a path to potentially reach the $108-$121 targets in the upcoming sessions. As always, keep an eye on market news and be prepared to adjust your strategy based on new information.

Disclaimer: This analysis is for informational purposes only and should not be taken as financial advice. Always conduct your research and consider your risk tolerance before investing in the stock market.

Dr SAUD

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.